Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. [electronic resource]
Producer: 20131223Description: 440-51 p. digitalISSN:- 1878-0261
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antigens, Bacterial -- administration & dosage
- Bacterial Toxins -- administration & dosage
- Cell Death -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Delivery Systems
- Drug Resistance, Neoplasm
- ErbB Receptors -- metabolism
- Humans
- Neoplasms -- drug therapy
- Receptor, ErbB-2 -- metabolism
- Recombinant Fusion Proteins -- administration & dosage
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.